$ONC
BeiGene, Ltd. Stock $onc

$onc Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000165130822000139 Filed on August 08, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$387.6M	$341.6M	$1.362B
YoY Change	87.77%	127.73%	1261.08%
Cost Of Revenue	$76.54M	$71.17M	$329.3M
YoY Change	61.44%	96.27%	116.72%
Gross Profit	$311.1M	$270.4M	$1.033B
YoY Change	95.62%	137.76%	102.73%
Gross Profit Margin	80.25%	79.16%	75.83%
Selling, General & Admin	$322.9M	$331.4M	$2.194B
YoY Change	19.93%	42.67%	60.31%
% of Gross Profit	103.8%	122.56%	212.34%
Research & Development	$426.4M	$378.2M	$2.825B
YoY Change	21.15%	6.21%	29.75%
% of Gross Profit	137.06%	139.87%	273.45%
Depreciation & Amortization	$15.21M	$14.46M	$192.8M
YoY Change	29.23%	28.85%	8.31%
% of Gross Profit	4.89%	5.35%	18.66%
Operating Expenses	$749.3M	$709.6M	$5.177B
YoY Change	20.62%	20.6%	39.34%
Operating Profit	-$438.4M	-$439.4M	-$4.144B
YoY Change	-5.18%	-7.46%	754.65%
Interest Expense	-$858.7M	-$816.2M	-$119.1M
YoY Change	-757.06%	1378.5%	-1693.08%
% of Operating Profit
Other Income/Expense, Net	-$125.6M	-$129.6M	$287.0K
YoY Change	-499.15%	14850.06%	-265.9%
Pretax Income	-$551.2M	-$557.6M	-$4.263B
YoY Change	27.28%	16.03%	33.29%
Income Tax	$6.318M	$13.86M	-$16.17M
% Of Pretax Income
Net Earnings	-$557.6M	-$571.4M	-$4.247B
YoY Change	34.72%	18.97%	798.44%
Net Earnings / Revenue	-143.84%	-167.3%	-311.74%
Basic Earnings Per Share	-$0.41	-$0.43
Diluted Earnings Per Share	-$0.41	-$0.43	-$3.182M
COMMON SHARES
Basic Shares Outstanding	1.350B shares	1.336B shares	1.220B shares
Diluted Shares Outstanding	1.345B shares	1.336B shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.97B	$27.80B	$6.618B
YoY Change	639.73%	534.35%	42.29%
Cash & Equivalents	$4.197B	$4.531B	$4.376B
Short-Term Investments	$2.653B	$1.729B	$2.242B
Other Short-Term Assets	$8.517B	$11.73B	$27.06M
YoY Change	684.49%	1045.46%	131.96%
Inventory	$290.9M	$262.2M	$242.6M
Prepaid Expenses
Receivables	$189.2M	$172.3M	$483.1M
Other Receivables	$51.31M	$107.0M	$12.01M
Total Short-Term Assets	$5.749B	$6.346B	$7.614B
YoY Change	29.7%	32.23%	53.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$681.9M	$633.1M	$587.6M
YoY Change	51.27%	60.21%	64.28%
Goodwill	$109.0K	$109.0K	$109.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$25.79M	$27.10M	$22.96M
YoY Change	-95.45%	-92.22%
Other Assets	$140.6M	$131.0M	$163.0M
YoY Change	-19.74%	-0.97%	44.18%
Total Long-Term Assets	$976.8M	$1.032B	$1.032B
YoY Change	14.45%	42.38%	61.24%
TOTAL ASSETS
Total Short-Term Assets	$5.749B	$6.346B	$7.614B
Total Long-Term Assets	$976.8M	$1.032B	$1.032B
Total Assets	$6.726B	$7.378B	$8.646B
YoY Change	27.23%	33.56%	54.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$252.1M	$234.4M	$262.4M
YoY Change	22.24%	38.81%	13.12%
Accrued Expenses	$410.3M	$454.2M	$558.1M
YoY Change	5.23%	13.87%	61.22%
Deferred Revenue	$145.0M	$163.4M	$187.4M
YoY Change	99.63%	156.89%
Short-Term Debt	$2.977B	$2.411B	$2.622B
YoY Change	7.86%	-11.23%	682.62%
Long-Term Debt Due	$441.3M	2.550B cnies	2.725B cnies
YoY Change	-84.52%	-9.16%	24.65%
Total Short-Term Liabilities	$1.411B	$1.398B	$1.600B
YoY Change	8.19%	12.56%	48.77%
LONG-TERM LIABILITIES
Long-Term Debt	$208.1M	1.241B cnies	1.288B cnies
YoY Change	-83.93%	-1.4%	7.49%
Other Long-Term Liabilities	$45.17M	$48.43M	$54.23M
YoY Change	-17.28%	-12.47%	-5.56%
Total Long-Term Liabilities	$659.5M	$677.3M	$803.4M
YoY Change	5.55%	0.33%	22.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.411B	$1.398B	$1.600B
Total Long-Term Liabilities	$659.5M	$677.3M	$803.4M
Total Liabilities	$2.071B	$2.076B	$2.403B
YoY Change	7.34%	8.26%	38.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.635B	-$5.972B	-$4.966B
YoY Change	51.47%	50.55%	39.78%
Common Stock	$135.0K	$134.0K	$133.0K
YoY Change	11.57%	11.67%	12.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.655B	$5.303B	$6.243B
YoY Change
Total Liabilities & Shareholders Equity	$6.726B	$7.378B	$8.646B
YoY Change	27.23%	33.56%	54.37%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$557.6M	-$571.4M	-$4.247B
YoY Change	34.72%	18.97%	798.44%
Depreciation, Depletion And Amortization	$15.21M	$14.46M	$192.8M
YoY Change	29.23%	28.85%	8.31%
Cash From Operating Activities	-$3.122B	-$1.376B	-$3.109B
YoY Change	-3.3%	-49.75%	28.25%
INVESTING ACTIVITIES
Capital Expenditures	-$723.7M	-$464.8M	-$1.240B
YoY Change	77.82%	72.48%	315.92%
Acquisitions
YoY Change
Other Investing Activities	$1.474B	$5.014B	$231.6M
YoY Change	9.85%	109.24%	-52.51%
Cash From Investing Activities	$750.2M	$4.549B	-$1.009B
YoY Change	-19.74%	113.9%	-632.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	750.3M	-150.8M	21.46B
YoY Change	18.68%	-207.77%	899.43%
NET CHANGE
Cash From Operating Activities	-3.122B	-1.376B	-3.109B
Cash From Investing Activities	750.2M	4.549B	-1.009B
Cash From Financing Activities	750.3M	-150.8M	21.46B
Net Change In Cash	-1.621B	3.022B	17.34B
YoY Change	-2.42%	-740.04%	-19856.64%
FREE CASH FLOW
Cash From Operating Activities	-$3.122B	-$1.376B	-$3.109B
Capital Expenditures	-$723.7M	-$464.8M	-$1.240B
Free Cash Flow	-$2.398B	-$911.4M	-$1.869B
YoY Change	-15.01%	-63.09%	-12.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001651308
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37686
	dei	Entity Registrant Name EntityRegistrantName	BEIGENE, LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1209416
	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Mourant Governance Services (Cayman) Limited
	dei	Entity Address Address Line2 EntityAddressAddressLine2	94 Solaris Avenue, Camana Bay
	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
	dei	Entity Address Country EntityAddressCountry	KY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-1108
	dei	City Area Code CityAreaCode	345
	dei	Local Phone Number LocalPhoneNumber	949-4123
	dei	Security12b Title Security12bTitle	American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	BGNE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1349639439	shares
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4531137000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4375678000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	333000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	328000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	1172554000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	2241962000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	172259000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	483113000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	262210000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	242626000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	207383000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	270173000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	6345876000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7613880000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3939000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6881000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	633100000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587605000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	117583000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	117431000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43325000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46679000	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	103429000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	110424000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	130955000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	163049000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1032331000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1032069000	usd
CY2022Q2	us-gaap	Assets Assets	7378207000	usd
CY2021Q4	us-gaap	Assets Assets	8645949000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	234355000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	262400000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	454183000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	558055000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	163396000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	187414000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	15564000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	21395000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24788000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21925000	usd
CY2022Q2	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	125394000	usd
CY2021Q4	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	120801000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	380729000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	427565000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1398409000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1599555000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	185207000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	202113000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	167570000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	220289000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	41921000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43041000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14739000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14169000	usd
CY2022Q2	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	219385000	usd
CY2021Q4	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	269561000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48432000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54234000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	677254000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	803407000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	2075663000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2402962000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1349639439	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1349639439	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1334804281	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1334804281	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	134000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	133000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11356686000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11191007000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-82450000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17950000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5971826000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4966103000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5302544000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6242987000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7378207000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8645949000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	341572000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	149992000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	648198000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	755864000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71173000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36263000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	136410000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68948000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	378207000	usd
CY2022Q2	bgne	Amortization Of Intangible Assets Included In Operating Expenses AmortizationOfIntangibleAssetsIncludedInOperatingExpenses	188000	usd
CY2021Q2	bgne	Amortization Of Intangible Assets Included In Operating Expenses AmortizationOfIntangibleAssetsIncludedInOperatingExpenses	187000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	356091000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	768122000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	676817000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	331403000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	232289000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	625976000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	414395000	usd
	bgne	Amortization Of Intangible Assets Included In Operating Expenses AmortizationOfIntangibleAssetsIncludedInOperatingExpenses	376000	usd
	bgne	Amortization Of Intangible Assets Included In Operating Expenses AmortizationOfIntangibleAssetsIncludedInOperatingExpenses	375000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	780971000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	624830000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1530884000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1160535000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-439399000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-571449000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-474838000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-882686000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-404671000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11431000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4866000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21502000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9045000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-129617000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-867000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-117650000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4990000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-557585000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-480571000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-978834000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-418706000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13864000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-230000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26889000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4860000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-480341000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1005723000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-413846000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1336463026	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1336463026	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1194071476	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1194071476	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1334252648	shares
CY2021Q2	bgne	Earnings Per American Depository Share Diluted EarningsPerAmericanDepositoryShareDiluted	-5.23
	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	-9.80
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1334252648	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1191521766	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1191521766	shares
CY2022Q2	bgne	Earnings Per American Depository Share Diluted EarningsPerAmericanDepositoryShareDiluted	-5.56
CY2022Q2	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	-5.56
CY2021Q2	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	-5.23
	bgne	Earnings Per American Depository Share Diluted EarningsPerAmericanDepositoryShareDiluted	-9.80
	bgne	Earnings Per American Depository Share Diluted EarningsPerAmericanDepositoryShareDiluted	-4.52
	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	-4.52
CY2022Q2	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	102804848	shares
CY2022Q2	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	102804848	shares
CY2021Q2	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	91851652	shares
CY2021Q2	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	91851652	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	102634819	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	102634819	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	91655520	shares
	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	91655520	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-571449000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-480341000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1005723000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-413846000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-97459000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	9626000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-88085000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	5864000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	136000	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-361000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-2445000	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	53500000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-599000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-12315000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1072000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-671353000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-471450000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1106123000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-408693000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1005723000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-413846000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32061000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21159000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	146860000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	110624000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-23529000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6033000	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	77204000	usd
	bgne	Amortization Of Research And Development Financing Liability AmortizationOfResearchAndDevelopmentFinancingLiability	-45583000	usd
	bgne	Amortization Of Research And Development Financing Liability AmortizationOfResearchAndDevelopmentFinancingLiability	-53902000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	7550000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-12311000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6360000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	11212000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-307430000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13338000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31633000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28294000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-32315000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30362000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-42558000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	19525000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1688000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-76737000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	138877000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2114000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3189000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-616522000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-295171000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	95421000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	80920000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	11504000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1357051000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1051028000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1997515000	usd
	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	75000000	usd
	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	8500000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	869103000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	543544000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	366000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10819000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	67586000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	112589000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	115405000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	15959000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	18972000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	35601000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28847000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	143050000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-71212000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5257000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	152522000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	396680000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4382887000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1390005000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4535409000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1786685000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4531137000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1776448000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	333000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	310000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3939000	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	9927000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	24436000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14527000	usd
	us-gaap	Interest Paid Net InterestPaidNet	12899000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14267000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	58676000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	28885000	usd
	bgne	Acquired In Process Research And Development But Not Yet Paid AcquiredInProcessResearchAndDevelopmentButNotYetPaid	0	usd
	bgne	Acquired In Process Research And Development But Not Yet Paid AcquiredInProcessResearchAndDevelopmentButNotYetPaid	45000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6242987000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	152000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	11880000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	65555000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-496000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-434274000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5885500000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7092000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81305000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-99904000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-571449000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5302544000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3869243000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	25754000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45833000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3738000	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	66495000	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4003587000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	9847000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	64791000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8891000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-480341000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3606775000	usd
CY2022Q2	bgne	Number Of Persons NumberOfPersons	2500	people
CY2022Q2	bgne	Product Candidate ProductCandidate	3	product
CY2022Q2	dei	Entity Number Of Employees EntityNumberOfEmployees	8600	employee
CY2022Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	29	country
CY2021Q2	bgne	Reimbursement Expense ReimbursementExpense	8352000	usd
	bgne	Reimbursement Expense ReimbursementExpense	22266000	usd
	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	366000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities and reported amounts of revenues and expenses. Actual results could differ from these estimates.</span></div>
CY2022Q1	bgne	Number Of Products Initiated Marketing And Promotion NumberOfProductsInitiatedMarketingAndPromotion	5	product
CY2022Q2	bgne	Reimbursement Expense ReimbursementExpense	10555000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	bgne	Reimbursement Expense ReimbursementExpense	15176000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	4272000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	7209000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	1184869000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	12315000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	1172554000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	2245662000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3700000	usd
CY2021Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	2241962000	usd
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	44033000	usd
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	43722000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	27100000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	22955000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	525048000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26889000	usd
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	82848000	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	78140000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	37992000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9397000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	141370000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	155089000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	262210000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	242626000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	602694000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	142561000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	124286000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	633100000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587605000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	14461000	usd
	us-gaap	Depreciation Depreciation	30041000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	11223000	usd
	us-gaap	Depreciation Depreciation	20667000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50332000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7007000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43325000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51710000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5031000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46679000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	304000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2020000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	492000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1989000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3972000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3972000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3972000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3972000	usd
CY2022Q2	bgne	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	25448000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43325000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13864000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-230000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4860000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11765000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	951000	usd
	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1840000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	415000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	112000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-210000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-46000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	3000	usd
	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	1000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	208000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	67000	usd
CY2022Q2	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	72474000	usd
CY2021Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	87239000	usd
CY2022Q2	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	59291000	usd
CY2021Q4	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	78538000	usd
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes	18627000	usd
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	58579000	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	17409000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	12010000	usd
CY2022Q2	us-gaap	Interest Receivable Current InterestReceivableCurrent	2611000	usd
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	5052000	usd
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	8462000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1695000	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	28509000	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	27060000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	207383000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	270173000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	109000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	109000	usd
CY2022Q2	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	14412000	usd
CY2021Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	14140000	usd
CY2022Q2	bgne	Prepaid Construction Cost PrepaidConstructionCost	21473000	usd
CY2021Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	24237000	usd
CY2022Q2	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	29000	usd
CY2021Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	17162000	usd
CY2022Q2	bgne	Rental Deposits And Other RentalDepositsAndOther	7345000	usd
CY2021Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	6609000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	87587000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	100792000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	130955000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	163049000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	124565000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	139966000	usd
CY2022Q2	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	151321000	usd
CY2021Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	213922000	usd
CY2022Q2	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	55366000	usd
CY2021Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	71560000	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	23525000	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	45661000	usd
CY2022Q2	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	71512000	usd
CY2021Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	59639000	usd
CY2022Q2	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	27894000	usd
CY2021Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	27307000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	454183000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	558055000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	185207000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1240500000	cny
CY2022Q2	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	40835000	usd
CY2021Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	46352000	usd
CY2022Q2	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	7484000	usd
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	7814000	usd
CY2022Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	113000	usd
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	68000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48432000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54234000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	380729000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2550096000	cny
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	427565000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2724732000	cny
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	202113000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1288000000	cny
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	5456000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	10984000	usd
CY2022Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	654000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1935000	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	7627000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	14577000	usd
CY2021Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	147000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	251000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-571449000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-480341000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1005723000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-413846000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1336463026	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1336463026	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1194071476	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1194071476	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1334252648	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1334252648	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1191521766	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1191521766	shares
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	81305000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	64791000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	146860000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110624000	usd
	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	109700000	usd
	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-100400000	usd
	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-100400000	usd
CY2022Q2	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2022Q2	bgne	Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital	0.50
CY2022Q2	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	341572000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	149992000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	648198000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	755864000	usd

Files In Submission

Name	View Source	Status
bgne-20220630_cal.xml	Edgar Link	unprocessable
bgne-20220630_htm.xml	Edgar Link	completed
bgne-20220630_lab.xml	Edgar Link	unprocessable
bgne-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bgne-20220630_def.xml	Edgar Link	unprocessable
0001651308-22-000139-index-headers.html	Edgar Link	pending
0001651308-22-000139-index.html	Edgar Link	pending
0001651308-22-000139.txt	Edgar Link	pending
0001651308-22-000139-xbrl.zip	Edgar Link	pending
a101-firstamendmenttocolla.htm	Edgar Link	pending
a103-rsuawardagreementempl.htm	Edgar Link	pending
a104-rsuawardagreementdire.htm	Edgar Link	pending
a105-rsuawardagreementcons.htm	Edgar Link	pending
a106-nqstockoptionagreemen.htm	Edgar Link	pending
a107-nqshareoptionagreemen.htm	Edgar Link	pending
a108-nqshareoptionagreemen.htm	Edgar Link	pending
bgne-20220630.htm	Edgar Link	pending
bgne-20220630.xsd	Edgar Link	pending
bgne-20220630_g1.jpg	Edgar Link	pending
exhibit311-2022q2.htm	Edgar Link	pending
exhibit312-2022q2.htm	Edgar Link	pending
exhibit321-2022q2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONC
BeiGene, Ltd. Stock $onc

2022 Q3 Form 10-Q Financial Statement

#000165130822000139 Filed on August 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC BeiGene, Ltd. Stock $onc

2022 Q3 Form 10-Q Financial Statement

#000165130822000139 Filed on August 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC
BeiGene, Ltd. Stock $onc